The proposed Center will incorporate administrative and scientific support functions in a single Core,referred to as the Administrative and Integration Core (A&l Core). Functioning within the larger institutionalenvironment of UCLA, including the affiliated UCLA Integrated Substance Abuse Programs (ISAP), theCenter will build on a proven framework that has improved efficiency and communication amonginvestigators involved in the proposed Center and in other UCLA centers. The organization ensures that theCenter will work formally to merge scientific disciplines and associated personnel in a coherent blending thatwill produce a translational research program yielding substantially more than the sum of its components.A&l Core will work toward the following specific aims: Provide an efficient infrastructure to support the four primary research projects of the Center and alimited program of pilot projects, including administrative, research, and clinical services; Facilitate communication and cooperation among Center investigators and provide opportunitiesfor interaction with other scientists on Center activities; Provide for central planning and coordination of Center activities within the larger context of otherresearch activities and programs at UCLA and in the community to support a Research CareerDevelopment and Training Program to identify, recruit, and provide training and mentoring to newinvestigators who will do translational research on the neurobiology of drug addiction; Promote dissemination of Center research products and methodological developments, ensuringthe Center's identity and function as a national resource that can transition to a P50 Center.The A&l Core will have four components: 1) the Administrative Unit, including Dr. E. London (Center andCore Director), Dr. R. Bilder (Director of Research Career Development and Training) and M. Walker(Administrative Coordinator); the Medical Services and Human Subjects Unit, directed by Dr. T. Newton(Acting Center Director and Core Director in Dr. London's absence) and including Dr. T. Fong (StaffPhysician) and C. Hurley (Recruiter); the Research Career Developmetn and Training Unit, directed by Dr.R. Bilder and including Dr.s C. Evans, E. London, J. Licinio, T. Newton, and R De La Garza; and theBiostatistics, Data Analysis and Data Management Unit, directed by Dr. J. Mintz, and including Dr. R.Poldrack (Functional Imaging Director), R. Nandy (Statistician), and S. Shih (Programmer/Systems Analyst).The Core is essential to the operation of the Center it brings together the external and internal academicresources with the day-to-day functions needed to accomplish Center objectives. It is the Core that providesthe foundation for the synergistic preparation of the next round of work, extending the early phase work ofthe P20 Center to form a mature Center.This program addresses a major public health problem - methampehtamine abuse, an underserved andunderstudied problem. It wroks to provide knowledge to advance development of therapeutic intervetionsand to train investigators who will be equipped to address this public health problem.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory Grants (P20)
Project #
5P20DA022539-03
Application #
7689044
Study Section
Special Emphasis Panel (ZDA1-MXS-M (06))
Project Start
2008-05-01
Project End
2010-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
3
Fiscal Year
2008
Total Cost
$240,737
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Dean, Andy C; Morales, Angelica M; Hellemann, Gerhard et al. (2018) Cognitive deficit in methamphetamine users relative to childhood academic performance: link to cortical thickness. Neuropsychopharmacology 43:1745-1752
Kong, Xiang-Zhen; Mathias, Samuel R; Guadalupe, Tulio et al. (2018) Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Proc Natl Acad Sci U S A 115:E5154-E5163
Kohno, Milky; Morales, Angelica M; Guttman, Zoe et al. (2017) A neural network that links brain function, white-matter structure and risky behavior. Neuroimage 149:15-22
Okita, Kyoji; Petersen, Nicole; Robertson, Chelsea L et al. (2016) Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence. Neuropsychopharmacology 41:2913-2919
Kohno, M; Okita, K; Morales, A M et al. (2016) Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users. Mol Psychiatry 21:1554-1560
Okita, Kyoji; Mandelkern, Mark A; London, Edythe D (2016) Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence. Int J Neuropsychopharmacol 19:
Jones, Hannah W; Dean, Andy C; Price, Kimberly A et al. (2016) Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence. Am J Drug Alcohol Abuse 42:500-506
Okita, Kyoji; Ghahremani, Dara G; Payer, Doris E et al. (2016) Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend 161:163-70
Okita, Kyoji; Ghahremani, Dara G; Payer, Doris E et al. (2016) Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals. Int J Neuropsychopharmacol 19:
Ballard, Michael E; Dean, Andy C; Mandelkern, Mark A et al. (2015) Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. PLoS One 10:e0143510

Showing the most recent 10 out of 72 publications